Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2015-08-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JAD-150307PMID 26401706PMCID PMC6080853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration

  2015cited by this paper
• A Single-Dose Pilot Trial of Intranasal Rapid-Acting Insulin in Apolipoprotein E4 Carriers with Mild–Moderate Alzheimer’s Disease

  2014cited by this paper
• Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice

  2014cited by this paper
• Brain metabolic dysfunction at the core of Alzheimer's disease.

  2014cited by this paper
• Central and Peripheral Administration of Antisense Oligonucleotide Targeting Amyloid-β Protein Precursor Improves Learning and Memory and Reduces Neuroinflammatory Cytokines in Tg2576 (AβPPswe) Mice

  2014cited by this paper
• Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin

  2014cited by this paper
• Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease.

  2014cited by this paper
• Selective Anesthesia-induced Neuroinflammation in Developing Mouse Brain and Cognitive Impairment

  2013cited by this paper
• IL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPARδ, SIRT1, PGC-1α, and PGC-1β expression in male mice.

  2013cited by this paper
• Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease

  2013influential reference
• Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study.

  2013cited by this paper
• Effects of single dose intranasal oxytocin on social cognition in schizophrenia.

  2013cited by this paper
• Peripheral Administration of Antisense Oligonucleotides Targeting the Amyloid-β Protein Precursor Reverses AβPP and LRP-1 Overexpression in the Aged SAMP8 Mouse Brain

  2012cited by this paper
• Anesthetic Isoflurane Increases Phosphorylated Tau Levels Mediated by Caspase Activation and Aβ Generation

  2012cited by this paper
• The Impact of Yangtze River Discharge, Ocean Currents and Historical Events on the Biogeographic Pattern of Cellana toreuma along the China Coast

  2012cited by this paper
• IL-15 Overexpression Promotes Endurance, Oxidative Energy Metabolism, and Muscle PPAR (cid:1) , SIRT1, PGC-1 (cid:2) , and PGC-1 (cid:3) Expression in Male Mice

  2012cited by this paper
• Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease.

  2012cited by this paper
• Intranasal delivery of biologics to the central nervous system.

  2012cited by this paper
• Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

  2012cited by this paper
• Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial

  2011cited by this paper
• Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance.

  2010cited by this paper
• New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer's disease?

  2010cited by this paper
• Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics.

  2008cited by this paper
• Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.

  2007cited by this paper
• Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.

  2006influential reference
• Effect of PAO (phenylarsine oxide) on the inhibitory effect of insulin and IGF-1 on insulin release from INS-1 cells.

  2006cited by this paper
• Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine

  2005cited by this paper
• The role of insulin receptor signaling in the brain.

  2005cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• On the delay-dependent involvement of the hippocampus in object recognition memory.

  2004cited by this paper
• Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.

  2004cited by this paper
• Intranasal insulin improves memory in humans.

  2004cited by this paper
• Antisense directed at the Aβ region of APP decreases brain oxidative markers in aged senescence accelerated mice

  2004cited by this paper
• The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

  2003cited by this paper
• Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

  2003cited by this paper
• Improving Influence of Insulin on Cognitive Functions in Humans

  2001cited by this paper
• Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse.

  2000cited by this paper
• The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses

  1999cited by this paper
• Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin.

  1998cited by this paper
• Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity

  1997cited by this paper
• Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin.

  1997influential reference
• Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain.

  1993cited by this paper
• Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas.

  1986cited by this paper
• Regional concentrations of insulin in the rat brain.

  1983cited by this paper
• REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I

  1966cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper

• Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists.

  2026cites this paper
• Use of intranasal insulin on postoperative delirium: A systematic review and meta-analysis of randomised controlled trials

  2026cites this paper
• Overcoming translational barriers in nose-to-brain drug delivery for clinical applications.

  2026cites this paper
• Potential Application of Nanotechnology in Type-3 Diabetes: Bridging Insulin Resistance and Neurodegeneration

  2025cites this paper
• Pathological mechanisms and treatment progression of Alzheimer’s disease

  2025cites this paper
• First‐in‐human positron emission tomography study of intranasal insulin in aging and MCI

  2025cites this paper
• Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial

  2025cites this paper
• Absence of Adverse Effects on Pulmonary Histopathology and Functions Following Inhalation Exposure to Chloromethylisothiazolinone/Methylisothiazolinone

  2025cites this paper
• Intranasal insulin in Alzheimer disease (diabetes in situ?): a systematic review and meta-analysis

  2025cites this paper
• Effect of antidiabetic drugs in Alzheimer´s disease: a systematic review of preclinical and clinical studies

  2025cites this paper
• Effect of perioperative intranasal insulin on postoperative delirium in elderly hip fracture patients undergoing general anesthesia: a randomized controlled study

  2025cites this paper
• Optimal Dose of Intranasal Insulin Administration for Reducing Postoperative Delirium Incidence in Older Patients Undergoing Hip Fracture Surgery.

  2025cites this paper
• Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease

  2025cites this paper
• Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer’s Disease and Parkinson’s Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies

  2025cites this paper
• Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties

  2024cites this paper
• Effect of Intranasal Insulin on Cognitive Function in Diabetic Patients

  2024cites this paper
• First Biodistribution Study of [68Ga]Ga-NOTA-Insulin Following Intranasal Administration in Adult Vervet Monkeys

  2024cites this paper
• Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach

  2024cites this paper
• Effects of a high-fat diet on cognition and brain distribution of intranasal insulin in E3 and E4 male and female mice

  2024cites this paper
• Alzheimer's disease as a form of in situ diabetes: A systematic review and meta-analysis of therapeutic approaches using intranasal insulin treatment

  2024cites this paper
• Intranasal Insulin Treatment Ameliorates Spatial Memory, Muscular Strength, and Frailty Deficits in 5xFAD Mice.

  2024cites this paper
• Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy

  2024influential citation
• Intranasal Delivery of Anti-Apoptotic siRNA Complexed with Fas-Signaling Blocking Peptides Attenuates Cellular Apoptosis in Brain Ischemia

  2024cites this paper
• An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting.

  2024cites this paper
• Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases.

  2024cites this paper
• Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials

  2023cites this paper
• State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease

  2023cites this paper
• Intranasal insulin alleviates traumatic brain injury by inhibiting autophagy and endoplasmic reticulum stress-mediated apoptosis through the PI3K/Akt/mTOR signaling pathway.

  2023cites this paper
• The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and “Nose-to-Brain”

  2023cites this paper
• Levodopa-loaded nanoparticles for the treatment of Parkinson's disease.

  2023cites this paper
• Administration of Nebulised Ketamine for Managing Pain in the Intensive Care Unit of Obstetrics and Gynaecology

  2023cites this paper
• The local GLP-1 system in the olfactory bulb is required for odor-evoked cephalic phase of insulin release in mice

  2023cites this paper
• How Can Insulin Resistance Cause Alzheimer’s Disease?

  2023cites this paper
• Hot Spots for the Use of Intranasal Insulin: Cerebral Ischemia, Brain Injury, Diabetes Mellitus, Endocrine Disorders and Postoperative Delirium

  2023cites this paper
• Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer's disease: In vitro, in vivo, and ex vivo evaluations.

  2022cites this paper
• Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update

  2022cites this paper
• Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer’s disease neuropathology

  2022cites this paper
• Glucose-lowering drugs, cognition, and dementia: the clinical evidence.

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Insulin blood-brain barrier transport and interactions are greater following exercise in mice.

  2022cites this paper
• Neuroprotective effects of Canagliflozin: Lessons from aged genetically diverse UM‐HET3 mice

  2022cites this paper
• Intranasal calcitonin gene-related peptide administration impairs fear memory retention in mice through the PKD/p-HDAC5/Npas4 pathway

  2022cites this paper
• Insulin stimulates atypical protein kinase C‐mediated phosphorylation of the neuronal adaptor FE65 to potentiate neurite outgrowth by activating ARF6‐Rac1 signaling

  2022cites this paper
• Falling Short: The Contribution of Central Insulin Receptors to Gait Dysregulation in Brain Aging

  2022cites this paper
• Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease

  2021cites this paper
• The Blood–Brain Barrier and CNS Drug Delivery

  2021cites this paper
• EVALUATION OF TAURINE’S NEUROPROTECTIVE EFFECTS ON SH-SY5Y CELLS UNDER OXIDATIVE STRESS

  2021cites this paper
• Intranasal Ketamine for Acute Pain: Behavioral and Neurophysiological Safety Analysis in Mice

  2021cites this paper
• Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.

  2021cites this paper
• Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)

  2021cites this paper
• Intranasal insulin for treatment of delirium in older hospitalised patients: study protocol for a randomised controlled trial

  2021cites this paper
• Neuroprotective effects of taurine on SH-SY5Y cells under hydrocortisone induced stress

  2021cites this paper
• Experimental models for evaluation of direct nose-to-brain drug delivery

  2021cites this paper
• A Comprehensive Review of Intranasal Insulin and Its Effect on the Cognitive Function of Diabetics

  2021cites this paper
• Repeated Preoperative Intranasal Administration of Insulin Decreases the Incidence of Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Radical Gastrointestinal Surgery: A Randomized, Placebo-Controlled, Double-Blinded Clinical Study.

  2021cites this paper
• The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS

  2021cites this paper
• Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: a systematic review.

  2021cites this paper
• Role of Insulin in Neurotrauma and Neurodegeneration: A Review

  2020cites this paper
• Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.

  2020cites this paper
• Intranasal insulin treatment modulates the neurotropic, inflammatory, and oxidant mechanisms in the cortex and hippocampus in a low-grade inflammation model.

  2020cites this paper
• Intranasal Insulin: a Treatment Strategy for Addiction

  2020cites this paper
• ApoE and cerebral insulin: Trafficking, receptors, and resistance.

  2020cites this paper
• Insulin mediated novel therapies for the treatment of Alzheimer's disease.

  2020cites this paper
• APOE and metabolic dysfunction in Alzheimer's disease.

  2020cites this paper
• Molecular elevation of insulin receptor signaling improves memory recall in aged Fischer 344 rats

  2020cites this paper
• Nasal Inflammation and Ulceration Secondary to Repeated Use of an Intranasal Delivery Device in Rabbits

  2020cites this paper
• Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin

  2020cites this paper
• Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation

  2020cites this paper
• Intranasal applications in Alzheimer's treatment

  2020influential citation
• Long-term administration of intranasal insulin improves peripheral glucose concentration in diabetic male rats

  2020cites this paper
• Distribution of insulin in trigeminal nerve and brain after intranasal administration

  2019cites this paper
• Disruption of the hippocampal and hypothalamic blood–brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate

  2019cites this paper
• Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice.

  2019cites this paper
• Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer’s Disease

  2019cites this paper
• Molecular Mechanisms of Intranasal Insulin in SAMP8 Mice

  2019influential citation
• Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice

  2019cites this paper
• Long-term intranasal insulin aspart: a profile of gene expression, memory, and insulin receptors in aged F344 rats.

  2019cites this paper
• Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance

  2019cites this paper
• Advancing Alzheimer’s Disease Treatment: Lessons from CTAD 2018

  2019cites this paper
• Insulin deficiency, but not resistance, exaggerates cognitive deficits in transgenic mice expressing human amyloid and tau proteins. Reversal by Exendin‐4 treatment

  2019cites this paper
• Combined Effect of Fatty Diet and Cognitive Decline on Brain Metabolism, Food Intake, Body Weight, and Counteraction by Intranasal Insulin Therapy in 3×Tg Mice

  2019cites this paper
• Routes for the delivery of insulin to the central nervous system: A comparative review.

  2019cites this paper
• Expression of insulin and GLP-1 receptors in interneurons of the cerebral cortex

  2019cites this paper
• Broadening the definition of brain insulin resistance in aging and Alzheimer's disease

  2019cites this paper
• Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice

  2019cites this paper
• Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease.

  2019cites this paper
• Role of green tea catechins in prevention of age‐related cognitive decline: Pharmacological targets and clinical perspective

  2018cites this paper
• The effect of intracerebroventricular administration of insulin on memory impairment-induced by scopolamine in male rats

  2018cites this paper
• Brain Diabetes: The New Type 3 Diabetes

  2018cites this paper
• Medical Issues, Therapies, and Treatments

  2018cites this paper
• Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer’s disease and normalized by treatment with anti-diabetic agents

  2018cites this paper
• Evaluation of intranasal delivery route of drug administration for brain targeting.

  2018cites this paper
• Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease

  2018cites this paper
• Insulin transport across the blood–brain barrier can occur independently of the insulin receptor

  2018cites this paper
• Mechanism of intranasal drug delivery directly to the brain

  2018cites this paper
• A review of brain insulin signaling in mood disorders: From biomarker to clinical target

  2018cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cites this paper
• Identification of Protein Kinase C Isoforms Involved in Type 1 Diabetic Encephalopathy in Mice

  2018cites this paper
• Safety of intranasal human insulin: A review

  2018cites this paper
• Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents

  2018cites this paper